chr22-30407568-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012429.5(SEC14L2):c.388C>A(p.Leu130Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,614,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012429.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEC14L2 | NM_012429.5 | c.388C>A | p.Leu130Met | missense_variant | 5/12 | ENST00000615189.5 | |
SEC14L2 | NM_033382.3 | c.388C>A | p.Leu130Met | missense_variant | 5/11 | ||
SEC14L2 | NM_001291932.2 | c.226C>A | p.Leu76Met | missense_variant | 4/11 | ||
SEC14L2 | NM_001204204.3 | c.174+1183C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEC14L2 | ENST00000615189.5 | c.388C>A | p.Leu130Met | missense_variant | 5/12 | 1 | NM_012429.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251330Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135864
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 727218
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152306Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.388C>A (p.L130M) alteration is located in exon 5 (coding exon 5) of the SEC14L2 gene. This alteration results from a C to A substitution at nucleotide position 388, causing the leucine (L) at amino acid position 130 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at